Don’t Let Protective Safeguards Become Your Policy’s Poison Pill

A recent federal court decision reminds insurance professionals and policyholders of the practical and legal consequences…

Don’t Let Protective Safeguards Become Your Policy’s Poison Pill

A recent federal court decision reminds insurance professionals and policyholders of the practical and legal consequences…

Eli Lilly reports successful Phase 3 trial for its new diabetes pill

If approved, the pill would compete with injectable GLP-1 drugs By Mark Huffman of ConsumerAffairs April…